PubMed

Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture.

Paintsil E, Grill SP, Dutschman GE, Cheng YC.

AIDS Res Ther. 2009 Apr 22;6:5.PMID: 19386130 [PubMed]Free PMC ArticleFree textRelated citations

Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.

Paintsil E, Dutschman GE, Hu R, Grill SP, Lam W, Baba M, Tanaka H, Cheng YC.

Antimicrob Agents Chemother. 2007 Nov;51(11):3870-9. Epub 2007 Aug 27.PMID: 17724147 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.

Carter MM, Torres SM, Cook DL Jr, McCash CL, Yu M, Walker VE, Walker DM.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):239-47.PMID: 17358029 [PubMed - indexed for MEDLINE]Related citations

Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells.

Wang X, Tanaka H, Baba M, Cheng YC.

Antimicrob Agents Chemother. 2009 Aug;53(8):3317-24. Epub 2009 May 26.PMID: 19470503 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.

Perez-Olmeda M, Garcia-Perez J, Mateos E, Spijkers S, Ayerbe MC, Carcas A, Alcami J.

J Med Virol. 2009 Feb;81(2):211-6.PMID: 19107982 [PubMed - indexed for MEDLINE]Related citations

Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.

Van Dyke RB, Wang L, Williams PL; Pediatric AIDS Clinical Trials Group 219C Team.

J Infect Dis. 2008 Dec 1;198(11):1599-608.PMID: 19000014 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.

Feng JY, Ly JK, Myrick F, Goodman D, White KL, Svarovskaia ES, Borroto-Esoda K, Miller MD.

Retrovirology. 2009 May 13;6:44.PMID: 19439089 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

FTC (emtricitabine, Emtriva).

[No authors listed]

Proj Inf Perspect. 2003 Oct;(36):6-7.PMID: 14696567 [PubMed - indexed for MEDLINE]Related citations

WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.

Walker DM, Kajon AE, Torres SM, Carter MM, McCash CL, Swenberg JA, Upton PB, Hardy AW, Olivero OA, Shearer GM, Poirier MC, Walker VE.

Environ Mol Mutagen. 2009 Jul;50(6):460-72.PMID: 19334055 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.

Li J, Li L, Li HP, Zhuang DM, Liu SY, Liu YJ, Bao ZY, Wang Z, Li JY.

Chin Med J (Engl). 2009 May 5;122(9):1081-6.PMID: 19493444 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.

Smith KY, Patel P, Fine D, Bellos N, Sloan L, Lackey P, Kumar PN, Sutherland-Phillips DH, Vavro C, Yau L, Wannamaker P, Shaefer MS; HEAT Study Team.

AIDS. 2009 Jul 31;23(12):1547-56.PMID: 19542866 [PubMed - indexed for MEDLINE]Related citations

Divergent effects of cell environment on HIV entry inhibitor activity.

Rusert P, Mann A, Huber M, von Wyl V, Gunthard HF, Trkola A.

AIDS. 2009 Jul 17;23(11):1319-27.PMID: 19579289 [PubMed - indexed for MEDLINE]Related citations

Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.

Matamoros T, Nevot M, Martínez MA, Menéndez-Arias L.

J Biol Chem. 2009 Nov 20;284(47):32792-802. Epub 2009 Sep 29.PMID: 19801659 [PubMed - indexed for MEDLINE]Related citations

Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.

Franssen R, Sankatsing RR, Hassink E, Hutten B, Ackermans MT, Brinkman K, Oesterholt R, Arenas-Pinto A, Storfer SP, Kastelein JJ, Sauerwein HP, Reiss P, Stroes ES.

Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1336-41. Epub 2009 Aug 10.PMID: 19667106 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine.

Yu M, Ward Y, Poirier MC, Olivero OA.

Environ Mol Mutagen. 2009 Oct;50(8):718-24.PMID: 19562754 [PubMed - indexed for MEDLINE]Related citations

High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.

Sivadasan A, Abraham OC, Rupali P, Pulimood SA, Rajan J, Rajkumar S, Zachariah A, Kannangai R, Kandathip AJ, Sridharan G, Mathai D.

J Assoc Physicians India. 2009 May;57:384-8.PMID: 19634284 [PubMed - in process]Related citations

An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors.

Wendelsdorf KV, Song Z, Cao Y, Samuels DC.

PLoS Comput Biol. 2009 Jan;5(1):e1000261. Epub 2009 Jan 9.PMID: 19132079 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo.

Poirier MC, Olivero OA, Hardy AW, Franchini G, Borojerdi JP, Walker VE, Walker DM, Shearer GM.

AIDS Res Ther. 2009 Nov 6;6:24.PMID: 19895691 [PubMed]Free PMC ArticleFree textRelated citations

Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures.

Robinson B, Li Z, Nath A.

J Neurovirol. 2007 Apr;13(2):160-7.PMID: 17505984 [PubMed - indexed for MEDLINE]Related citations

HIV sensitivity to neutralization is determined by target and virus producer cell properties.

Mann AM, Rusert P, Berlinger L, Kuster H, Günthard HF, Trkola A.

AIDS. 2009 Aug 24;23(13):1659-67.PMID: 19581791 [PubMed - indexed for MEDLINE]Related citations